Casandra
Casandra Test Code QD30401Version 1 (DRAFT)
Performing Lab
Neuron Specific Enolase (NSE), Serum
Clinical Use
Order TestUse
Quantitative determination of NSE in serum may be valuable in the management of patients with suspected or diagnosed small‑cell lung carcinoma (SCLC) or neuroblastoma, to monitor the effect of treatment, to aid in the detection of recurrent disease, and to evaluate prognosis in patients.([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/JWRubyMemorial/test/664800?utm_source=openai))
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Immunofluorescence Assay)
Biomarkers
Neuron Specific Enolase
AnalyteNeuron Specific Enolase • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Causes for Rejection
Hemolysis
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Neuron-specific Enolase (NSE)
Labcorp
Neuron-Specific Enolase, Serum
Mayo Clinic Lab
Neuron Specific Enolase, Serum
ARUP Laboratories
Neuron-specific Enolase (NSE) (Serial Monitor)
Labcorp
CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
ARUP Laboratories
Neurofilament Light Chain, Serum
Labcorp
Chromogranin A, Serum
Mayo Clinic Lab
Chromogranin A, Serum
ARUP Laboratories